{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:22:08Z","timestamp":1769516528544,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1287,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bbmt.2011.04.003","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T07:09:21Z","timestamp":1303196961000},"page":"1555-1561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intravenous Busulfan-Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"17","author":[{"given":"Wei","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Bao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.04.003_bib1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM197406202902501","article-title":"Bone marrow transplantation for hematologic neoplasia in 16 patients with identical twins","volume":"290","author":"Fefer","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2011.04.003_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2011.04.003_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","article-title":"Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen","volume":"70","author":"Tutschka","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.exphem.2003.09.008","article-title":"Busulfan-cyclophosphamide versus total body irradiation\u2013cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?","volume":"31","author":"Ferry","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157488407779422249","article-title":"Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring","volume":"2","author":"Nath","year":"2007","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib6","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","article-title":"Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide","volume":"84","author":"Clift","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib7","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V85.8.2263.bloodjournal8582263","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)","volume":"85","author":"Devergie","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1399-0012.2001.150304.x","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans","volume":"15","author":"Kim","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.bmt.1702802","article-title":"Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients","volume":"27","author":"Kroger","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/beha.2003.0232","article-title":"Stem cell transplantation in adult ALL patients","volume":"15","author":"Avivi","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10428190903419130","article-title":"Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis","volume":"51","author":"Xu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2011.04.003_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","article-title":"Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation","volume":"25","author":"Grochow","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00558081","article-title":"Pharmacokinetic and metabolic studies of high-dose busulphan in adults","volume":"36","author":"Hassan","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1200\/JCO.2000.18.2.340","article-title":"Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia","volume":"18","author":"Davies","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib16","first-page":"285","article-title":"Allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan","volume":"90","author":"Kim","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.04.003_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/bbmt.2002.v8.pm12374453","article-title":"Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation","volume":"8","author":"Fernandez","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib18","first-page":"3599","article-title":"Incidence and outcome of\u00a0hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2011.04.003_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib21","unstructured":"Lee ET, editor. Statistical Methods for Survival Data Analysis. Belmont, CA: Lifetime Learning; 1980 p. 355."},{"key":"10.1016\/j.bbmt.2011.04.003_bib22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib23","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1182\/blood-2010-02-269571","article-title":"Allogeneic stem cell transplantation for adult Philadelphia chromosome\u2013negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission","volume":"116","author":"Nishiwaki","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/bbmt.2002.v8.pm12374452","article-title":"Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for intravenous BuCy2 in chronic myelogenous leukemia","volume":"8","author":"Andersson","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V104.11.349.349","article-title":"Matched pairs analysis of IV vs PO busulfan as a conditioning agent prior to transplantation. ASH Annual Meeting abstract","volume":"104","author":"Sobocinski","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","article-title":"Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation","volume":"74","author":"Gluckman","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib27","first-page":"242","article-title":"A trial use of prophylactic low-dose lipo PGE1 (Eglandin) for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in children with hematologic malignancies","volume":"7","author":"Cho","year":"2000","journal-title":"Korean J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bbmt.2011.04.003_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3346\/jkms.2006.21.5.897","article-title":"Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children","volume":"21","author":"Song","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.bbmt.2011.04.003_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1399-0012.2007.00664.x","article-title":"Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation","volume":"21","author":"Cho","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/bmt.2008.372","article-title":"Busulfex (iv BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study","volume":"43","author":"Kim","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib31","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","article-title":"Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome","volume":"100","author":"Deeg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2002-11-3567","article-title":"Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells","volume":"102","author":"Bornh\u00e4user","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbmt.2008.11.022","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation","volume":"15","author":"Bartelink","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.04.003_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood-2008-07-168625","article-title":"Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison","volume":"113","author":"Cornelissen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib35","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL): an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.04.003_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.thj.6200353","article-title":"Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia","volume":"5","author":"Reman","year":"2004","journal-title":"Hematol J"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111001741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111001741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:40:03Z","timestamp":1761057603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111001741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1083879111001741"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.04.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Busulfan-Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Blood and Marrow Transplation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}